| Arvindselvan Mohanaselvan, MD | |
|
311 W I St, Los Banos, CA 93635-3479 | |
| (209) 826-2222 | |
| (209) 827-9998 |
| Full Name | Arvindselvan Mohanaselvan |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 3 Years |
| Location | 311 W I St, Los Banos, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316472400 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | A171869 (California) | Secondary |
| 207R00000X | Internal Medicine | A171869 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hospital Los Banos | Los banos, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kd Medical Group Inc | 2860553468 | 6 |
| Karthikeya Devireddy Md Inc | 3072566728 | 6 |
News Archive
Theraclone Sciences, Inc., a therapeutic antibody discovery and development company, announced today that they have entered into a multi-year research and development collaboration with Pfizer. The collaboration will use Theraclone's I-STAR™ technology to discover broadly protective monoclonal antibodies against up to four undisclosed targets in the areas of infectious disease and cancer.
Adults with type 2 diabetes requiring insulin therapy can safely achieve good blood sugar control using regular human insulin (RHI) in a wearable, patch-like insulin delivery device called V-Go®, a new study finds.
Cochlear implants are a groundbreaking technology that has changed the lives of many people living with severe to profound hearing loss.
Researchers from Italy determined that radiofrequency ablation (RFA) is a safe and effective therapy for managing hepatocellular carcinoma (HCC) in cirrhotic patients. The high repeatability of RFA is advantageous in controlling recurrences of cancerous tumors in the liver. Results of this 10-year retrospective study are available in the January 2011 issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD).
U.S. colleges with the biggest student drinking problems have so far failed to turn the tide, according to a new study.
› Verified 2 days ago
| Entity Name | Karthikeya Devireddy Md Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518089507 PECOS PAC ID: 3072566728 Enrollment ID: O20080115000741 |
News Archive
Theraclone Sciences, Inc., a therapeutic antibody discovery and development company, announced today that they have entered into a multi-year research and development collaboration with Pfizer. The collaboration will use Theraclone's I-STAR™ technology to discover broadly protective monoclonal antibodies against up to four undisclosed targets in the areas of infectious disease and cancer.
Adults with type 2 diabetes requiring insulin therapy can safely achieve good blood sugar control using regular human insulin (RHI) in a wearable, patch-like insulin delivery device called V-Go®, a new study finds.
Cochlear implants are a groundbreaking technology that has changed the lives of many people living with severe to profound hearing loss.
Researchers from Italy determined that radiofrequency ablation (RFA) is a safe and effective therapy for managing hepatocellular carcinoma (HCC) in cirrhotic patients. The high repeatability of RFA is advantageous in controlling recurrences of cancerous tumors in the liver. Results of this 10-year retrospective study are available in the January 2011 issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD).
U.S. colleges with the biggest student drinking problems have so far failed to turn the tide, according to a new study.
› Verified 2 days ago
| Entity Name | Kd Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457522567 PECOS PAC ID: 2860553468 Enrollment ID: O20081201000491 |
News Archive
Theraclone Sciences, Inc., a therapeutic antibody discovery and development company, announced today that they have entered into a multi-year research and development collaboration with Pfizer. The collaboration will use Theraclone's I-STAR™ technology to discover broadly protective monoclonal antibodies against up to four undisclosed targets in the areas of infectious disease and cancer.
Adults with type 2 diabetes requiring insulin therapy can safely achieve good blood sugar control using regular human insulin (RHI) in a wearable, patch-like insulin delivery device called V-Go®, a new study finds.
Cochlear implants are a groundbreaking technology that has changed the lives of many people living with severe to profound hearing loss.
Researchers from Italy determined that radiofrequency ablation (RFA) is a safe and effective therapy for managing hepatocellular carcinoma (HCC) in cirrhotic patients. The high repeatability of RFA is advantageous in controlling recurrences of cancerous tumors in the liver. Results of this 10-year retrospective study are available in the January 2011 issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD).
U.S. colleges with the biggest student drinking problems have so far failed to turn the tide, according to a new study.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Arvindselvan Mohanaselvan, MD 311 W I St, Los Banos, CA 93635-3479 Ph: (209) 826-2222 | Arvindselvan Mohanaselvan, MD 311 W I St, Los Banos, CA 93635-3479 Ph: (209) 826-2222 |
News Archive
Theraclone Sciences, Inc., a therapeutic antibody discovery and development company, announced today that they have entered into a multi-year research and development collaboration with Pfizer. The collaboration will use Theraclone's I-STAR™ technology to discover broadly protective monoclonal antibodies against up to four undisclosed targets in the areas of infectious disease and cancer.
Adults with type 2 diabetes requiring insulin therapy can safely achieve good blood sugar control using regular human insulin (RHI) in a wearable, patch-like insulin delivery device called V-Go®, a new study finds.
Cochlear implants are a groundbreaking technology that has changed the lives of many people living with severe to profound hearing loss.
Researchers from Italy determined that radiofrequency ablation (RFA) is a safe and effective therapy for managing hepatocellular carcinoma (HCC) in cirrhotic patients. The high repeatability of RFA is advantageous in controlling recurrences of cancerous tumors in the liver. Results of this 10-year retrospective study are available in the January 2011 issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD).
U.S. colleges with the biggest student drinking problems have so far failed to turn the tide, according to a new study.
› Verified 2 days ago
Gopi Krishna Polasa Venkata, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 311 W I St, Los Banos, CA 93635 Phone: 209-826-2222 | |
Dr. Jason Rinaldo Mevi, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 245 H St, Suite 2, Los Banos, CA 93635 Phone: 209-826-3200 Fax: 209-826-1354 | |
Dr. Sina Aghaie, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 311 W I St, Los Banos, CA 93635 Phone: 209-826-2222 | |
Dr. Michael Phillip Friedlander, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 520 W I St, Los Banos, CA 93635 Phone: 209-826-0591 | |
Dr. Vijay Devireddy, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 311 W I St, Los Banos, CA 93635 Phone: 209-826-2222 | |
Mr. Karthikeya Devireddy, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 311 W I St, Los Banos, CA 93635 Phone: 209-826-2222 Fax: 209-826-6554 |